Back
Relay Therapeutics Stock Price Chart
Sponsored
RLAY
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
31
RLAY
Relay Therapeutics
Last Price:
7.84
Seasonality Move:
-5.33%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLAY is experiencing slight selling pressure.
Relay Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.1 | Sell |
20-day SMA: | 7.33 | Buy |
50-day SMA: | 7.6 | Sell |
200-day SMA: | 8.23 | Sell |
8-day EMA: | 7.68 | Sell |
20-day EMA: | 7.48 | Buy |
50-day EMA: | 7.39 | Buy |
200-day EMA: | 8.22 | Sell |
Relay Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 51.35 | Buy |
Chaikin Money Flow: | -606265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.45 - 8.01) | Buy |
Bollinger Bands (100): | (6.39 - 8.03) | Buy |
Relay Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.58 while RLAY 8-day simple moving average is 8.10, which is a Sell signal.
- The stock price of RLAY is 7.58 while Relay Therapeutics 20-day SMA is 7.33, which makes it a Buy.
- Relay Therapeutics 50-day simple moving average is 7.60 while RLAY share price is 7.58, making it a Sell technically.
- RLAY stock price is 7.58 and Relay Therapeutics 200-day simple moving average is 8.23, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Sell
The current Relay Therapeutics [RLAY] share price is $7.58. The Score for RLAY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Relay Therapeutics Stock Info
Market Cap:
1.01B
Price in USD:
7.58
Share Volume:
1.48M
Relay Therapeutics 52-Week Range
52-Week High:
12.14
52-Week Low:
5.70
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 7.58 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.58 while RLAY 8-day exponential moving average is 7.68, which is a Sell signal.
- The stock price of RLAY is 7.58 while Relay Therapeutics 20-day EMA is 7.48, which makes it a Buy.
- Relay Therapeutics 50-day exponential moving average is 7.39 while RLAY share price is 7.58, making it a Buy technically.
- RLAY stock price is 7.58 and Relay Therapeutics 200-day simple moving average is 8.22, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.03 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Relay Therapeutics is a Buy
- Relay Therapeutics Relative Strength Index (RSI) is 51.35, which suggest Relay Therapeutics is overbought
- The Bollinger Bands (25) for Relay Therapeutics is (6.45 - 8.01), which suggest Relay Therapeutics is a Buy
- The Bollinger Bands (100) for Relay Therapeutics is (6.39 - 8.03), which suggest Relay Therapeutics is a Buy
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.